Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

Human Cell Design

Tracked across 1 events · 6 articles · First seen Sep 09, 2026 · Last active Sep 11, 2026

Sentiment
40
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 40
Business
Revvity, Inc. (NYSE: RVTY) announced on September 9, 2026 that it has entered into a definitive agreement to acquire Human Cell Design (HCD), a France-based biotechnology company specializing in human cell models and preclinical research…
Impact: Human Cell Design is the France-based acquisition target, bringing its EndoC-betaH5 cell models and NatLine platform to a broader global customer base under Revvity ownership.
Sep 09, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Human Cell Design live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.